ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID LAU M.D., PHD

Clinical Cardiac Electrophysiology

3,892

$392K

701
653 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 34%

$101
Average prescription price

Avg: $87

GEORGE VASSOLAS M.D.

Clinical Cardiac Electrophysiology

3,186

$208K

303
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 34%

$65
Average prescription price

Avg: $87

ADAM BUDZIKOWSKI M.D., PH.D.

Clinical Cardiac Electrophysiology

2,329

$180K

264
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 34%

$77
Average prescription price

Avg: $87

ROBERT JOY M.D.

Clinical Cardiac Electrophysiology

2,231

$192K

286
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 34%

$86
Average prescription price

Avg: $87

AFZAL REHMAN MD, PHD.

Clinical Cardiac Electrophysiology

2,129

$133K

307
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 34%

$63
Average prescription price

Avg: $87

THOR MARKWOOD MD

Clinical Cardiac Electrophysiology

1,956

$132K

339
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 34%

$67
Average prescription price

Avg: $87

ALFONSO PRIETO MD

Clinical Cardiac Electrophysiology

1,763

$203K

339
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 34%

$115
Average prescription price

Avg: $87

ROBERT PHANG M.D.

Clinical Cardiac Electrophysiology

1,606

$206K

313
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 34%

$128
Average prescription price

Avg: $87

SHOSHANAH KAHN M.D.,

Clinical Cardiac Electrophysiology

1,570

$61.1K

174
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 34%

$39
Average prescription price

Avg: $87

WILLIAM FRUMKIN M.D.

Clinical Cardiac Electrophysiology

1,537

$151K

190
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 34%

$98
Average prescription price

Avg: $87

AARON BERGER MD

Clinical Cardiac Electrophysiology

1,455

$88.6K

132
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 34%

$61
Average prescription price

Avg: $87

PARAG PATEL M.D.

Clinical Cardiac Electrophysiology

1,353

$91.3K

253
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 34%

$67
Average prescription price

Avg: $87

JEFFREY MATOS M.D

Clinical Cardiac Electrophysiology

1,191

$92.5K

98
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 34%

$78
Average prescription price

Avg: $87

LARRY CHINITZ M.D.

Clinical Cardiac Electrophysiology

1,038

$109K

161
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 34%

$105
Average prescription price

Avg: $87

SARAH TAYLOR MD

Clinical Cardiac Electrophysiology

1,029

$90.5K

207
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 34%

$88
Average prescription price

Avg: $87

KWABENA BOAHENE MD

Clinical Cardiac Electrophysiology

1,005

$96.6K

134
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 34%

$96
Average prescription price

Avg: $87

GRZEGORZ ROZMUS MD

Clinical Cardiac Electrophysiology

994

$117K

148
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 34%

$118
Average prescription price

Avg: $87

GUILLERMO SOSA-SUAREZ M.D.

Clinical Cardiac Electrophysiology

951

$117K

186
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 34%

$123
Average prescription price

Avg: $87

ABRAR SHAH MD

Clinical Cardiac Electrophysiology

939

$93.6K

180
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 34%

$100
Average prescription price

Avg: $87

MARCIN KOWALSKI MD

Clinical Cardiac Electrophysiology

903

$73.5K

209
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 34%

$81
Average prescription price

Avg: $87

MOHAN RAO M. D.

Clinical Cardiac Electrophysiology

879

$38.5K

51
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 34%

$44
Average prescription price

Avg: $87

CESARE SAPONIERI MD

Clinical Cardiac Electrophysiology

830

$28.9K

136
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 34%

$35
Average prescription price

Avg: $87

DAVENDRA MEHTA M.D.

Clinical Cardiac Electrophysiology

803

$82.6K

163
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 34%

$103
Average prescription price

Avg: $87

JOYA GANGULY MD

Clinical Cardiac Electrophysiology

731

$46.5K

131
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 34%

$64
Average prescription price

Avg: $87

JOSEPH GERMANO DO

Clinical Cardiac Electrophysiology

662

$54.1K

139
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 34%

$82
Average prescription price

Avg: $87

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank